SCHEMBL3489482

SCHEMBL3489482

COCCCOOC(=O)c1ccc(C=O)c(OCCCOC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
SMPD1 P17405 3/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
PRSS1 P07477 2/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
KDM4E B2RXH2 2/20 0.34
USP2 O75604 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373279 0.87 HDAC6 (0.50) HDAC6SMN1; SMN2KMT2AMAPTCYP1A2
SCHEMBL3488752 0.84 TSHR (0.46) ALDH1A1HPGDHTTMAPTCYP2C9
SCHEMBL3488798 0.83 ALDH1A1 (0.39) ALDH1A1HPGDSMN1; SMN2KMT2AHTT
SCHEMBL17311463 0.81 MAPT (0.47) ALDH1A1HPGDSMN1; SMN2KMT2AHTT
SCHEMBL3978102 0.76 MAPT (0.44) ALDH1A1HPGDSMN1; SMN2KMT2AHTT
SCHEMBL22160259 0.75 FDPS (0.57) ALDH1A1HPGDSMN1; SMN2HTTMAPT
SCHEMBL2811212 0.75 KDM4E (0.46) ALDH1A1HPGDSMN1; SMN2KMT2AHTT
SCHEMBL21046450 0.74 EGFR (0.48) ALDH1A1KMT2AHTTMAPT
SCHEMBL28646030 0.74 ALDH1A1 (0.47) ALDH1A1HPGDSMN1; SMN2KMT2AHTT
SCHEMBL23459305 0.72 MAPT (0.49) ALDH1A1KMT2AHTTMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056497-A1 AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD (JP) 2010-03-04 US disclosed
EP-2119702-A1 AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056497-A1 AMIDE DERIVATIVE REN, AGTR1, AGTR2 HDAC6 405/4885ALDH1A1 348/4885HPGD 1367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.